• Retina Controversy: Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases

  • Nov 17 2023
  • Duración: 16 m
  • Podcast

Retina Controversy: Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases Por arte de portada

Retina Controversy: Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • On this episode, Dr. Timothy Murray welcomes Dr. Baruch Kuppermann, Gavin Herbert Eye Institute, University of California, Irvine, California, to explore evidence from other specialties regarding cross-switching between biosimilars, and learn if there are any foreseen patient safety concerns for retina specialists.

    For more information visit www.ASRS.org/JVRDForum.

    Welcome to ASRS’s Journal of Vitreoretinal Diseases (JVRD) Author’s Forum. JVRD is the official scientific peer-reviewed journal of the American Society of Retina Specialists (ASRS) offering the highest quality and most impactful research and clinical information in the field. Join host Dr. Timothy Murray, Editor-in-Chief for JVRD as he discusses cutting-edge developments featured in JVRD with the lead authors who share clinical pearls and explore their significance for advancing patient care.

    Audio episodes are available on Amazon Music, Apple Podcasts, Google Podcasts, Spotify and other podcast directories.

    Explore the podcast
    Más Menos
activate_primeday_promo_in_buybox_DT
Enfermedades Físicas Hygiene & Healthy Living
Más Menos

Lo que los oyentes dicen sobre Retina Controversy: Biosimilar to Biosimilar Anti-VEGF Switching for Retinal Diseases

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles